Skip to main content
. 2022 Jun 9;13:868809. doi: 10.3389/fimmu.2022.868809

Table 2.

Tumor responses.

Tumor response, n (%) All patients (n = 133) Training set (n = 93) Validation set (n = 40)
Complete response (CR) 1 (0.8) 1 (1.1) 0
Partial response (PR) 30 (22.6) 19 (20.4) 11 (27.5)
Stable disease (SD) 65 (48.9) 46 (49.5) 19 (47.5)
Progressive disease (PD) 37 (27.8) 27 (29.0) 10 (25.0)
ORR (CR + PR)* 31 (23.4) 20 (21.5) 11 (27.5)
DCR (CR + PR + SD)# 96 (72.2) 66 (71.0) 30 (75.0)

DCR, disease control rate; ORR, objective response rate.

*Pearson χ² = 0.562, P = 0.453 (ORR comparison between the validation and training sets).

#Pearson χ² = 0.226, P = 0.634 (DCR comparison between the validation and training sets).